We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+12.8%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$1.15B
AUM Growth
+$94.9M
Cap. Flow
-$28.4M
Cap. Flow %
-2.46%
Top 10 Hldgs %
35.53%
Holding
265
New
17
Increased
43
Reduced
110
Closed
7

Top Buys

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$4.4M
2
NXPI icon
NXP Semiconductors
NXPI
+$2.49M
3
HON icon
Honeywell
HON
+$1.85M
4
CRM icon
Salesforce
CRM
+$1.15M
5
LIN icon
Linde
LIN
+$732K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$3.53M
2
PYPL icon
PayPal
PYPL
+$2.57M
3
MSFT icon
Microsoft
MSFT
+$2.14M
4
TMO icon
Thermo Fisher Scientific
TMO
+$2M
5
DHR icon
Danaher
DHR
+$1.4M

Sector Composition

Rank Sector Weight
1 Technology 21.09%
2 Healthcare 19.74%
3 Financials 13.98%
4 Industrials 11.33%
5 Communication Services 8.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCD icon
26
McDonald's
MCD
$195B
$13.8M 1.19%
64,189
BRK.B icon
27
Berkshire Hathaway Class B
BRK.B
$1.13T
$13.3M 1.16%
57,558
+377
+0.7% +$83K
PWR icon
28
Quanta Services
PWR
$101B
$13.1M 1.13%
181,213
-19,432
-10% -$1.28M
COST icon
29
Costco
COST
$420B
$12.8M 1.11%
33,917
+547
+2% +$204K
PG icon
30
Procter & Gamble
PG
$339B
$12.6M 1.09%
90,617
-6,786
-7% -$948K
BX icon
31
Blackstone
BX
$110B
$12.6M 1.09%
193,929
-12,136
-6% -$707K
UNH icon
32
UnitedHealth
UNH
$370B
$12.4M 1.07%
35,365
-35
-0.1% -$11.7K
J icon
33
Jacobs Solutions
J
$17B
$11.8M 1.02%
130,959
-4,165
-3% -$353K
CRM icon
34
Salesforce
CRM
$158B
$11.5M 0.99%
51,586
+4,735
+10% +$1.15M
BMY icon
35
Bristol-Myers Squibb
BMY
$132B
$9.94M 0.86%
160,229
-9,175
-5% -$564K
PEP icon
36
PepsiCo
PEP
$190B
$9.53M 0.83%
64,281
-4,040
-6% -$574K
ORCL icon
37
Oracle
ORCL
$423B
$9.28M 0.8%
143,435
-12,990
-8% -$773K
INTC icon
38
Intel
INTC
$513B
$9.23M 0.8%
185,277
-13,957
-7% -$682K
IBB icon
39
iShares Biotechnology ETF
IBB
$9.71B
$8.51M 0.74%
56,151
-2,440
-4% -$349K
EMR icon
40
Emerson Electric
EMR
$88.3B
$8.49M 0.74%
105,700
-2,800
-3% -$208K
VZ icon
41
Verizon
VZ
$196B
$8.02M 0.69%
136,470
-5,952
-4% -$354K
BXMT icon
42
Blackstone Mortgage Trust
BXMT
$2.38B
$7.96M 0.69%
289,095
-48,343
-14% -$1.22M
BP icon
43
BP
BP
$107B
$7.21M 0.62%
351,254
-1,026
-0.3% -$19.3K
AXP icon
44
American Express
AXP
$230B
$6.83M 0.59%
56,449
-9,818
-15% -$1.09M
CVS icon
45
CVS Health
CVS
$122B
$6.63M 0.57%
96,996
-824
-0.8% -$53.6K
ABT icon
46
Abbott
ABT
$187B
$6.46M 0.56%
59,033
NKE icon
47
Nike
NKE
$61.9B
$6.29M 0.54%
44,478
+3,252
+8% +$431K
RTX icon
48
RTX Corp
RTX
$301B
$6.24M 0.54%
87,275
+324
+0.4% +$21.3K
GDX icon
49
VanEck Gold Miners ETF
GDX
$27.4B
$6.11M 0.53%
169,532
-2,438
-1% -$91.1K
ADP icon
50
Automatic Data Processing
ADP
$108B
$6.08M 0.53%
34,527
+20
+0.1% +$3.29K

Similar funds

Neville Rodie & Shaw's Q4 2020 Portfolio in Review

As of Q4 2020, Neville Rodie & Shaw held 265 positions worth $1.15B, up 9% from $1.06B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Neville Rodie & Shaw's Q4 2020 filing shows 17 new, 43 increased, 110 reduced and 7 closed positions. Its largest new stake was NXP Semiconductors: 16,910 shares worth $2.69M. The largest sale was Apple, an estimated $3.53M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Neville Rodie & Shaw's largest Q4 2020 buy was NXP Semiconductors: 16,910 shares worth $2.69M.
  • Neville Rodie & Shaw added most to Union Pacific in Q4 2020, an estimated $4.4M increase.
  • Neville Rodie & Shaw's biggest Q4 2020 reduction was Apple, cutting an estimated $3.53M.
  • Neville Rodie & Shaw fully exited Invesco S&P 500 Equal Weight Consumer Discretionary ETF in Q4 2020, selling an estimated $597K.
  • Neville Rodie & Shaw's ten largest holdings make up 36% of its $1.15B portfolio in Q4 2020.
  • Neville Rodie & Shaw opened 17 new positions and closed 7 in Q4 2020.
  • Neville Rodie & Shaw's portfolio value rose 9% quarter-over-quarter to $1.15B.

Based on Neville Rodie & Shaw's 13F filing for Q4 2020, filed 4 Mar 2021.